Metastatic Melanoma in Sentinel Node–Negative Patients: The Ottawa Experience

Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients

(2016) Marloes Faut et al.   ANNALS OF SURGICAL ONCOLOGY

Predictors and patterns of melanoma recurrence following a negative sentinel lymph node biopsy

(2016) Emer P. O’Connell et al.   MELANOMA RESEARCH

Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed?

(2015) M. J. Speijers et al.   ANNALS OF SURGICAL ONCOLOGY

The role ofBRAFmutations in primary melanoma growth rate and survival

(2015) V.J. Mar et al.   BRITISH JOURNAL OF DERMATOLOGY

Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients

(2013) M. Schlaak et al.   BRITISH JOURNAL OF DERMATOLOGY

Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma

(2013) Dale Han et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term Follow-up and Survival of Patients Following a Recurrence of Melanoma After a Negative Sentinel Lymph Node Biopsy Result

(2013) Edward L. Jones et al.   JAMA Surgery

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline

(2012) Sandra L. Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

NRAS mutation status is an independent prognostic factor in metastatic melanoma

(2011) John A. Jakob et al.   CANCER

Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities

(2011) F. Wright et al.   CLINICAL ONCOLOGY

Long-term follow-up reveals that ulceration and sentinel lymph node status are the strongest predictors for survival in patients with primary cutaneous melanoma

(2011) M. de Vries et al.   EJSO

Sentinel lymph node biopsy in melanoma: The Oxford ten year clinical experience

(2011) Milap G. Rughani et al.   Journal of Plastic Reconstructive and Aesthetic Surgery

Clinically relevant information from sentinel lymph node biopsies of melanoma patients

(2011) Duan-Ren Wen et al.   JOURNAL OF SURGICAL ONCOLOGY

Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma

(2011) Bianca Devitt et al.   Pigment Cell & Melanoma Research

Thick primary melanoma has a heterogeneous tumor biology: an institutional series

(2011) Ari-Nareg Meguerditchian et al.   World Journal of Surgical Oncology

Melanoma sentinel node biopsy and prediction models for relapse and overall survival

(2010) A Mitra et al.   BRITISH JOURNAL OF CANCER

New developments in sentinel node staging in melanoma: controversies and alternatives

(2010) Alexander CJ van Akkooi et al.   CURRENT OPINION IN ONCOLOGY

Sentinel lymph node biopsy and melanoma: 2010 update

(2010) William G. Stebbins et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Final Version of 2009 AJCC Melanoma Staging and Classification

(2009) Charles M. Balch et al.   JOURNAL OF CLINICAL ONCOLOGY